Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Mennini

Showing results (181-190 of 189) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 189 results.
Journal of Medicinal Chemistry|September 28, 1998
New antipsychotic agents with serotonin and dopamine antagonist properties based on a pyrrolo[2,1-b][1,3]benzothiazepine structureG Campiani, V Nacci, S Bechelli, et al.
Rejuvenation Research|October 8, 2011
Intracerebroventricular administration of human umbilical cord blood cells delays disease progression in two murine models of motor neuron degenerationP Bigini, P Veglianese, G Andriolo, et al.
Journal of Medicinal Chemistry|November 2, 1999
Pyrroloquinoxaline derivatives as high-affinity and selective 5-HT(3) receptor agonists: synthesis, further structure-activity relationships, and biological studiesG Campiani, E Morelli, S Gemma, et al.
Journal of Medicinal Chemistry|July 27, 2001
A rational approach to the design of selective substrates and potent nontransportable inhibitors of the excitatory amino acid transporter EAAC1 (EAAT3). new glutamate and aspartate analogues as potential neuroprotective agentsG Campiani, M De Angelis, S Armaroli, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 22, 2001
Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stressA L Sirén, M Fratelli, M Brines, et al.
Journal of Medicinal Chemistry|August 30, 1996
Synthesis, biological activity, and SARs of pyrrolobenzoxazepine derivatives, a new class of specific "peripheral-type" benzodiazepine receptor ligandsG Campiani, V Nacci, I Fiorini, et al.
Journal of Medicinal Chemistry|July 19, 1996
Cardiovascular characterization of pyrrolo[2,1-d][1,5]benzothiazepine derivatives binding selectively to the peripheral-type benzodiazepine receptor (PBR): from dual PBR affinity and calcium antagonist activity to novel and selective calcium entry blockersG Campiani, I Fiorini, M P De Filippis, et al.
European Journal of Pharmacology|December 19, 1996
Mechanism of inhibition of tumor necrosis factor production by chlorpromazine and its derivatives in miceP Ghezzi, S Garattini, T Mennini, et al.
Journal of Medicinal Chemistry|December 14, 2001
Characterization of the 1H-cyclopentapyrimidine-2,4(1H,3H)-dione derivative (S)-CPW399 as a novel, potent, and subtype-selective AMPA receptor full agonist with partial desensitization propertiesG Campiani, E Morelli, V Nacci, et al.
Pageof 19

Showing results (181-190 of 189) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 189 results.
Journal of Medicinal Chemistry|September 28, 1998
New antipsychotic agents with serotonin and dopamine antagonist properties based on a pyrrolo[2,1-b][1,3]benzothiazepine structureG Campiani, V Nacci, S Bechelli, et al.
Rejuvenation Research|October 8, 2011
Intracerebroventricular administration of human umbilical cord blood cells delays disease progression in two murine models of motor neuron degenerationP Bigini, P Veglianese, G Andriolo, et al.
Journal of Medicinal Chemistry|November 2, 1999
Pyrroloquinoxaline derivatives as high-affinity and selective 5-HT(3) receptor agonists: synthesis, further structure-activity relationships, and biological studiesG Campiani, E Morelli, S Gemma, et al.
Journal of Medicinal Chemistry|July 27, 2001
A rational approach to the design of selective substrates and potent nontransportable inhibitors of the excitatory amino acid transporter EAAC1 (EAAT3). new glutamate and aspartate analogues as potential neuroprotective agentsG Campiani, M De Angelis, S Armaroli, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 22, 2001
Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stressA L Sirén, M Fratelli, M Brines, et al.
Journal of Medicinal Chemistry|August 30, 1996
Synthesis, biological activity, and SARs of pyrrolobenzoxazepine derivatives, a new class of specific "peripheral-type" benzodiazepine receptor ligandsG Campiani, V Nacci, I Fiorini, et al.
Journal of Medicinal Chemistry|July 19, 1996
Cardiovascular characterization of pyrrolo[2,1-d][1,5]benzothiazepine derivatives binding selectively to the peripheral-type benzodiazepine receptor (PBR): from dual PBR affinity and calcium antagonist activity to novel and selective calcium entry blockersG Campiani, I Fiorini, M P De Filippis, et al.
European Journal of Pharmacology|December 19, 1996
Mechanism of inhibition of tumor necrosis factor production by chlorpromazine and its derivatives in miceP Ghezzi, S Garattini, T Mennini, et al.
Journal of Medicinal Chemistry|December 14, 2001
Characterization of the 1H-cyclopentapyrimidine-2,4(1H,3H)-dione derivative (S)-CPW399 as a novel, potent, and subtype-selective AMPA receptor full agonist with partial desensitization propertiesG Campiani, E Morelli, V Nacci, et al.
Pageof 19